Frontiers in Drug Discovery
Country
Switzerland
Western Europe
Subject Area and Category
Medicine
└
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1
└
Drug Discovery
Q2
└
Medicine (miscellaneous)
Q2
Publisher
SJR 2025
0.873
Q1
SJR Score
H-Index
15
Citations / Doc (2yr)
5.61
Total Docs. (latest)
18
Total Citations (3yr)
535
Publication type
Journals
ISSN
26740338
Coverage
2021-2026
Journal Rank
#6,051
Subject Categories
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1
Drug Discovery
Q2
Medicine (miscellaneous)
Q2
Pharmacology
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 18 |
| Total Docs. (3 years) | 121 |
| Total Refs. | 1,103 |
| Total Citations (3 years) | 535 |
| Citable Docs. (3 years) | 108 |
| Citations / Doc. (2 years) | 5.61 |
| Ref. / Doc. | 61.28 |
| % Female | 39.1% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Frontiers in Drug Discovery?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Frontiers in Drug Discovery has an SJR of 0.873 and is ranked Q1.
What is the SJR and quartile of Frontiers in Drug Discovery?
Frontiers in Drug Discovery has an SJR (SCImago Journal Rank) of 0.873 and its best quartile is Q1.
What is the H-index of Frontiers in Drug Discovery?
The H-index of Frontiers in Drug Discovery is 15, meaning 15 of its articles have each been cited at least 15 times.
Is Frontiers in Drug Discovery indexed in Scopus?
Yes. Frontiers in Drug Discovery is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.